Clinical Trials Directory

Trials / Conditions / Moderate to Severe Ulcerative Colitis

Moderate to Severe Ulcerative Colitis

8 registered clinical trials studyying Moderate to Severe Ulcerative Colitis — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingUniversal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
NCT07309744
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEARLY_Phase 1
RecruitingA Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulc
NCT06693908
Genentech, Inc.Phase 1 / Phase 2
Active Not RecruitingPhase II Study of Hemay005 in Patients With Active Ulcerative Colitis
NCT05486104
Ganzhou Hemay Pharmaceutical Co., LtdPhase 2
UnknownA Cohort Study Comparing IFX to CS for Moderate to Severe UC
NCT04879966
Sixth Affiliated Hospital, Sun Yat-sen University—
CompletedA Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Coliti
NCT04090411
Hoffmann-La RochePhase 2
CompletedA Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (U
NCT04700449
Connect Biopharm LLCPhase 2
WithdrawnA Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
NCT03627052
Incyte CorporationPhase 2
TerminatedFecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Unde
NCT02092389
AbbVie—